mRNA licensing agreements surge 800% amid GSK lawsuits
mRNA-based innovator pharmaceuticals have experienced a massive increase in licensing agreement deal values following success with the technology in Covid-19…
mRNA-based innovator pharmaceuticals have experienced a massive increase in licensing agreement deal values following success with the technology in Covid-19…
A Phase I/II trial (NCT05603312) with MeiraGTx's AAV-GAD Parkinson’s disease gene therapy has met its primary endpoint. The sham-controlled bridging…
As the number of mpox-related deaths in the Democratic Republic of Congo (DRC) and neighbouring countries continues to climb, international…
Mostly centred in the Democratic Republic of Congo DRC) and its African neighbours, the current outbreak of mpox has been…
Anti-obesity drugs will be the most impactful trend of 2024, followed by personalised and precision medicine, immuno-oncology (IO) drug development,…
A new study published in the British Medical Journal found potential in the use of psilocybin to treat depression, with…
Psychedelic treatments have been considered in the treatment of mental health since the 1950s, following Albert Hofmann’s development of lysergic…
A new report by GlobalData has found that Remote Patient Monitoring (RPM) devices are a growing sector, expected to be…